Anti-Toxoplasma gondii Antibodies in Haemodialysis Patients
Kavous Solhjoo1, Abdolreza Sotoodeh Jahromi1 & Ayeh Parnian-Rad1 Show affiliations
- Jahrom University of Medical Sciences, Iran
American Journal of Infectious Diseases, Volume 6, Issue 1, pp. 13–17 · doi.org/10.3844/ajidsp.2010.13.17
Abstract
Problem statement: In situations of immunodeficiency, Toxoplasma gondii emerges as a life-threatening infection. Toxoplasma gondii is transmitted parenterally, flourish in immunocompromised subjects and, most toxoplasma infections are asymptomatic. Studies have shown that there is a immunodeficiency in renal failure patient such as hemodialysis patients and these patients have a high risk for many infections. There is no evidence about toxoplasmosis in hemodialysis patients in Iran. Approach: In the present study, we aimed to investigate the prevalence of anti-T. gondii antibodies in hemodialysis patients with chronic renal failure. This case-control study was carried out on 44 hemodialysis patients and 44 healthy controls for the prevalence of anti-T. gondii antibodies by ELISA. Anti-IgG, IgM and IgA T. gondii antibodies positivity were found to be 26 (59.10%), 3 (6.80%) and 3 (6.80%) of the 44 hemodialysis patients, respectively and 16 (36.40%) of the 44 control subjects were Anti-IgG T. gondii antibodies positivity and all of control subjects were negative for Anti-IgM and IgA T. gondii antibodies. The difference between them was statistically significant (p = 0.032). In addition, an increase of the seropositivity rate was detected with increasing length of time on hemodialysis treatment, indicating a statistically significant difference between these 2 parameters (p<0.001). Results: These findings confirm a high prevalence of toxoplasma infection in hemodialysis patients and these patients are a risk group for toxoplasma infection. Results showed that 3 hemodialysis patients had an acute and active infection. Conclusion: Moreover, it is recommended that hemodialysis patients who are susceptible to toxoplasma infections should be identified by T. gondii IgG and IgM and/or IgA specific serological tests. Therefore, patients undergoing hemodialysis should be screened for toxoplasma before dialysis to prevent the dissemination of this infection through the hemodialysis procedure.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2010 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Solhjoo, K., Jahromi, A. S. & Parnian-Rad, A. (2010). Anti-Toxoplasma gondii Antibodies in Haemodialysis Patients. American Journal of Infectious Diseases, 6(1), 13–17. https://doi.org/10.3844/ajidsp.2010.13.17
- Licence
- © Science Publications
- Issue
- Volume 6, Issue 1
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
